RPCEC00000386尚未招募未知
Exploratory, controlled, randomized and open clinical trial to evaluate the therapeutic effect and safety of oral Lithium Carbonate, combined with standard therapy, in patients with mild or moderate COVID-19. (COVID-19) - CLOC-2
Institute of Basic and Preclinical Sciences Victoria de Giron0 个研究点目标入组 192 人开始时间: 2021年8月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 192
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled trial. Masking: Open. Control group: Active. Assignment: Parallel. Purpose: Treatment
入排标准
- 年龄范围
- 19 years 至 one（—）
- 性别
- All
入选标准
- •1.Patient who expresses his consent to participate in the study in writing
- •2.Patients with positive RT-PCR
- •3.Age greater than or equal to 19 years
- •4.Mild or moderate symptomatic patients
排除标准
- •1. Patients with decompensated chronic diseases (high blood pressure, diabetes mellitus, ischemic heart disease, chronic obstructive pulmonary disease, asthma, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmias, Addison's disease)
- •2. Patients with immunosuppression due to cancer, HIV or long-term treatment with immunosuppressants
- •3. Patients with chronic kidney failure
- •4. Patients with digestive autoimmune diseases (Crohn's disease, ulcerative colitis, among others) or thyroid
- •5. Pregnant or breastfeeding
- •6. Patients with treatments that deplete sodium or maintain a sodium restrictive diet
- •7. Patients with psychiatric illnesses or mental disabilities that prevent them from expressing their willingness to participate in the study or make its evaluation difficult
- •8. Patients hypersensitive to lithium
- •9. Lactose intolerant patients
- •10. Woman of childbearing age who does not use contraception and does not undertake to use it for at least one month after the end of the study treatment.
- •11. Patient participating in another clinical trial at the time of selection
研究者
相似试验
招募中
1 期
Anti SARS-CoV-2 gammaglobuliCoronavirus InfectionsCOVID-19SARS-CoV2SARS VirusCoronaviridae InfectionsBetacoronavirusRPCEC00000379AICA Laboratorories Company30
招募中
2 期
Prospective, exploratory, randomized, controlled, double-blind, phase IIa clinical trial in a cross-over design to evaluate the safety and tolerability and potential clinical effects of BC007 in patients with post-COVID syndrome.Post-COVID-SyndromeDRKS00032237niversitätsklinikum Erlangen30
进行中（未招募）
不适用
Open, randomized, prospective, controlled, multicentre study to evaluate the efficacy and safety of multiple intraportal applications of liver cell suspension in patients with acute liver failure not eligible for orthotopic liver transplantatioAcute Liver FailureSubgroups of patients with indications falling under ICD classification codes:K70.4, K71, K72, K75, K76, K77MedDRA version: 9.1Level: LLTClassification code 10049844Term: Acute liver failureEUCTR2005-000837-39-DECytonet GmbH & Co. KG90
进行中（未招募）
不适用
Open, randomized, prospective, controlled, multicentre study to evaluate the efficacy and safety of multiple intraportal applications of liver cell suspension in patients with acute liver failure not eligible for orthotopic liver transplantatioAcute Liver FailureSubgroups of patients with indications falling under ICD classification codes:K70.4, K71, K72, K75, K76, K77MedDRA version: 9.1Level: LLTClassification code 10049844Term: Acute liver failureEUCTR2005-000837-39-GBCytonet GmbH & Co. KG90
进行中（未招募）
不适用
Open, randomized, prospective, controlled, multicentre study to evaluate the efficacy and safety of multiple intraportal applications of liver cell suspension in patients with acute liver failure not eligible for orthotopic liver transplantationEstudio abierto, aleatorizado, prospectivo controlado y multicéntrico para la evaluación de la efectividad y la seguridad de la administración reiterada de una suspensión de células hepáticas por la vena porta a pacientes con insuficiencia hepática aguda para los que no es factible efectuar un trasplante ortotópico de hígadoInsuficiencia hepática aguda (IHA) Subgrupos de pacientes con indicationes según ICD classification codes: K70.4, K71, K72, K75, K76, K77MedDRA version: 9.1Level: LLTClassification code 10049844Term: Acute liver failureEUCTR2005-000837-39-ESCytonet GmbH & Co. KG90